Editorial: Diabetes: A pandemic, a development issue or both?

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 3, 2010, Pages 305-309

  Colagiuri, Ruth ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSAL ATTRIBUTION; CLIMATE CHANGE; DIABETES CONTROL; ECONOMIC ASPECT; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANDEMIC; POLITICAL PARTICIPATION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; CARDIOVASCULAR DISEASE; EPIDEMIC; FEMALE; HEALTH; HEALTH PROMOTION; HOSPITALIZATION; MALE; METHODOLOGY; PRIMARY PREVENTION; RISK ASSESSMENT; STATISTICS; SURVIVAL;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; FEMALE; HEALTH PROMOTION; HUMANS; MALE; PREVALENCE; PRIMARY PREVENTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; WORLD HEALTH;

EID: 77949457245     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.12     Document Type: Editorial

References (26)

1. International Diabetes Federation. Diabetes Atlas 2000. International Diabetes Federation, Brussels, Belgium (2001).
2. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J. Psychosom. Res. 53(6), 1053-1060 (2002).
3. Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet. Med. 25(7), 878-881 (2008).
4. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26(2), 510-513 (2003).
5. Yang JK, Feng Y, Yuan MY et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet. Med. 23(6), 623-628 (2006).
6. Commonwealth Heads of Government Meeting. Statement on Commonwealth action to combat non-communicable diseases. Commonwealth Heads of Government Meeting, Republic of Trinidad and Tobago, 27-29 November 2009.
7. Leeder SR, Raymond S, Greenberg H, Liu H, Esson K. A race against time. The challenge of cardiovascular disease in developing economies. The Trustees of Columbia University, NY, USA (2004).
8. Colagiuri S, Brnabic A, Gomez M, Fitzgerald B, Buckley A, Colagiuri R. Diabco$t Australia Type 1: assessing the burden of Type 1 diabetes in Australia. Diabetes Australia, Canberra, Australia (2009).
9. Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J. Occup. Environ. Med. 49(6), 672-679 (2007).
10. Tunceli K, Bradley CJ, Nerenz D et al. The impact of diabetes on employment and work productivity. Diabetes Care 28(11), 2662-2667 (2005).
11. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 31(3), 596-615 (2008).
12. Tukuitonga C. Meeting of Health Ministers for the Pacific Island Countries. Vanuatu, 12-15 March 2007.
13. The Diabetes Control and Complications Trial (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977-986 (1993).
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study UKPDS group. Lancet 352(9131), 837-853 (1998).
15. Colagiuri R, Eigenmann CA. A national consensus on outcomes and indicators for diabetes patient education. Diabet. Med. 26, 442-446 (2009).
16. American Association of Diabetes Educators. Standards for outcomes measurements of diabetes self-management education. Position Statement. Diabetes Educator 29, 804-816 (2003).
17. Majumdar SR, Johnson JA, Bowker SL, Booth GL. A Canadian consenus for the standardized evaluation of quality improvement interventions in Type 2 diabetes. Can. J. Diabetes 29, 220-229 (2005).
18. Knowler W, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393-403 (2002).
19. Kosaka K, Noda M, Kuzuya T. Prevention of Type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res. Clin. Pract. 67(2), 152-162 (2005).
20. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4), 537-544 (1997).
21. Ramachandran A, Snehalatha C, Mary S et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent Type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2), 289-297 (2006).
22. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344(18), 1343-1350 (2001).
23. Edwards P, Roberts I. Population adiposity and climate change. Int. J. Epidemiol. 38(4), 1137-1140 (2009).
24. Haines A, McMichael AJ, Smith KR et al. Public health benefits of strategies to reduce greenhouse-gas emissions: overview and implications for policy makers. Lancet 374(9707), 2104-2114 (2009).
25. Sacks J. The Politics of Hope. Vintage, London, UK (1997).
26. Pramming S, Colagiuri R. Can public health advocates work alongside industry? Med. J. Aust. 188(4), 202-203 (2008).